Acute Pain
Arthritis, Gouty
Ductus Arteriosus, Patent
Indomethacin
Spondylitis, Ankylosing

Indomethacin

Indomethacin is a potent nonsteroidal anti-inflammatory drug with broad applications. The drug inhibits prostaglandin synthesis produced by cyclooxygenase enzymes, which are critical mediators of inflammation, fever, and pain. Indomethacin is approved by the US Food and Drug Administration (FDA) to manage acute pain, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, bursitis, gouty arthritis, and patent ductus arteriosus. Clinicians often use indomethacin as a supportive treatment within a medication regimen. This activity focuses on the indications, contraindications, and administration methods of indomethacin as a valuable therapeutic agent, as well as its key factors, such as off-label uses, dosing, pharmacokinetics, monitoring, and relevant interactions. This activity underscores the crucial role of interprofessional healthcare teams in monitoring indomethacin therapy by tailoring treatment plans to individual patient needs depending on pain acuity, making informed decisions, and optimizing dosage regimens while minimizing adverse reactions. This evidence-based approach improves patient outcomes in inflammatory conditions treated with indomethacin.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.